Zum Hauptinhalt springen

Journal of the American Medical Association

Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries

Importance The World Health Organization is developing a global strategy to eliminate cervical cancer, with goals for screening prevalence among women aged 30 through 49 years. However, evidence on prevalence levels of cervical cancer screening in low- and middle-income countries (LMICs) is sparse. Objective To determine lifetime cervical cancer screening prevalence in LMICs and its variation across and within world regions and countries. Design, Setting, and Participants Analysis of cross-sectional nationally representative household surveys carried out in 55 LMICs from 2005 through 2018. The median response rate across surveys was 93.8% (range, 64.0%-99.3%). The population-based sample consisted of 1 136 289 women aged 15 years or older, of whom 6885 (0.6%) had missing information for the survey question on cervical cancer screening. Exposures World region, country; countries’ economic, social, and health system characteristics; and individuals’ sociodemographic characteristics. Main Outcomes and Measures Self-report of having ever had a screening test for cervical cancer.

Lemp, J., J. De Neve, H. Bussmann, S. Chen, J. Manne-Goehler, M. Theilmann, M. Marcus, C. Ebert, C. Probst, L. Tsabedze-Sibanyoni, L. Sturua, J. Kibachio, S. Moghaddam, J. Martins, D. Houinato, C. Houehanou, M. Gurung, G. Gathecha, F. Farzadfar, S. Dryden-Peterson, J. Davies, R. Atun, S. Vollmer, T. Bärnighausen und P. Geldsetzer (2020), Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries. Journal of the American Medical Association, 324, 15, 1532-1542

DOI: 10.1001/jama.2020.16244